CAN-2409 + valacyclovir
LuTK01
Phase 1 mab completed
Quick answer
CAN-2409 + valacyclovir for Lung Cancer is a Phase 1 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Candel Therapeutics
- Indication
- Lung Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed